[关键词]
[摘要]
目的 观察稳心颗粒联合普罗帕酮治疗室性心动过速的临床疗效。方法 将200例室性心动过速患者随机分为观察组和对照组,每组各100例。对照组给予普罗帕酮,观察组给予稳心颗粒联合普罗帕酮,4周后观察治疗效果。结果 观察组总有效率(91.0%)显著高于对照组(80.0%),差异具有统计学意义(P<0.05)。两组患者心率、血压、P-R间期和Q-T间期治疗前后比较,差异无统计学意义。两组不良反应发生率比较,差异无统计学意义。结论 稳心颗粒联合普罗帕酮能够显著降低室性心动过速发作,提高治疗效果,安全性高,值得临床推广。
[Key word]
[Abstract]
Objective To observe the clinical effect of propafenone combined with Wenxin Granule for treating patients with ventricular tachycardia. Methods Totally 200 patients with ventricular tachycardia were divided into observation group and control group randomly, each group had 100 cases. The control group was treated with propafenone, the observation group was treated with propafenone combined with Wenxin Granule. The effects were observed after 4 weeks. Results The total effective rate of the observation group was higher than that of the control group, and the difference was statistically significant (P<0.05). The heart rate, blood pressure, P-R interval, and Q-T of the two groups before and after treatment were compared, and the difference was not statistically significant. There was no significant difference in adverse reactions between two groups. Conclusion Propafenone combined with Wenxin Granule could significantly reduce the ventricular tachycardia and improve the therapeutic effect. The safety is good, it is worthy of clinical promotion.
[中图分类号]
[基金项目]